Executive Vice President, President, Clinical Diagnostics Group · BIO-RAD LABORATORIES, INC. (BIO)

Eva Engelhardt

FY2024 is the first fiscal year CompBrief holds for Eva Engelhardt as a named executive officer of BIO-RAD LABORATORIES; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2024

$2,230,746

Salary $292,789Stock awards $1,829,300Bonus $50,000

5th of 5 named executive officers at BIO-RAD Laboratories by FY2024 total.

5 named officers on file for BIO-RAD LABORATORIES, FY2024

Eva Engelhardt’s pay file — $29

  • 1 fiscal year of pay, line by line
  • 2 equity grants, each cited to its filing
  • BIO’s disclosed peer group of 23 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how BIO-RAD LABORATORIES’s whole pay program stands against its peers

  • BIO-RAD LABORATORIES’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on BIO→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed March 26, 2025 (DEF 14A).

Free

Get Eva Engelhardt’s full pay file as a PDF — free

More than this page: up to 10 years of Eva’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Eva Engelhardt compensation by year

BIO-RAD LABORATORIES Summary Compensation Table · the one fiscal year held
In US dollars, as BIO-RAD LABORATORIES reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2024
Salary$292,789
Bonus$50,000
Stock awards$1,829,300
Non-equity incentive$56,573
All other$2,084
Total$2,230,746

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: BIO-RAD LABORATORIES, INC. DEF 14A filed March 26, 2025, accession 0001308179-25-000235, and prior-year filings. Open the filing on EDGAR.

How this page was built: the BIO-RAD LABORATORIES, INC. filed document, accession 0001308179-25-000235. Every figure is read from that document and cited to the page and table it appears in. Filed March 26, 2025.

Equity holdings

unvested awards at FY2024 year-end
TypeUnvested unitsValue at year-endExercise price
RSU4,608$1,513,774—
RSU983$322,925—

Per the Outstanding Equity Awards at Fiscal Year-End table in BIO-RAD LABORATORIES, INC.'s FY2024 proxy; value at the fiscal year-end close, as the company printed it.

BIO-RAD LABORATORIES’s named executive officers, FY2024

as the company reported each
Named executive officerRoleFY2024 total
Norman SchwartzChief Executive Officer and Chairman$8,289,471
Jonathan DiVincenzoPresident and Chief Operating Officer$4,314,185
Roop LakkarajuExecutive Vice President, Chief Financial Officer$3,775,075
Michael CrowleyExecutive Vice President, Global Commercial Operations$2,241,366
Eva Engelhardt · this pageExecutive Vice President, President, Clinical Diagnostics Group$2,230,746

The full BIO-RAD LABORATORIES compensation record

free company brief

This page is one person within BIO-RAD LABORATORIES's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the BIO-RAD LABORATORIES proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are BIO-RAD LABORATORIES's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Eva Engelhardt's compensation dossier · One-time report. No refunds.